Finanzwire Finanzwire
Basculer en Français
11177 Companies
247156 Keywords
175004 Articles
133504 Press releases
Headlines Articles Press releases InvIOs GmbH Remove
  1. Home
  2. Companies
  3. InvIOs GmbH
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 11/09/2023 at 11:30, 2 years 11 months ago

    invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma

    Logo of InvIOs GmbH
  • PRESS RELEASE

    published on 09/05/2023 at 09:00, 3 years 1 month ago

    invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding

    Logo of InvIOs GmbH
  • PRESS RELEASE

    published on 06/19/2023 at 14:30, 3 years 3 months ago

    invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors

    Logo of InvIOs GmbH
  • PRESS RELEASE

    published on 04/18/2023 at 15:00, 3 years 5 months ago

    invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023

    Logo of InvIOs GmbH
Previous page
1 2
Accesswire
  • Published on 10/15/2026 at 12:30, 29 minutes ago

    Jaguar Mining Inc. Reports 30% Year-Over-Year Gold Production Growth in Q3 2026

  • Published on 10/15/2026 at 11:00, 1 hour 59 minutes ago

    Blue Lagoon Records Its First Finalized Gold And Silver Production From Dome Mountain

  • Published on 10/15/2026 at 08:07, 4 hours 52 minutes ago

    Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder

  • Published on 10/15/2026 at 08:02, 4 hours 57 minutes ago

    Southern Energy Corp. Announces Successful Cotton Valley Completion Results at Williamsburg

  • Published on 10/15/2026 at 01:35, 11 hours 24 minutes ago

    Presentation to Australian Gold Conference

View all ACCESSWIRE
EQS Group
  • Published on 10/15/2026 at 12:47, 12 minutes ago

    Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3202009547

  • Published on 10/15/2026 at 12:43, 15 minutes ago

    Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3195123065

  • Published on 10/15/2026 at 12:40, 18 minutes ago

    Turkiye Garanti Bankasi A.S.: Board of Directors Resolution Regarding the Issuance of Asset-Backed Securities

  • Published on 10/15/2026 at 12:37, 21 minutes ago

    Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3200020363

  • Published on 10/15/2026 at 12:10, 49 minutes ago

    MetaTech AP Unveils 2027 Growth Strategy, Partners with Zheng Yang Biomedical to Build a Regenerative Medicine Supply Chain

View all EQS
Les Echos
  • Published on 10/15/2026 at 07:27, 5 hours 31 minutes ago

    Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals

  • Published on 10/14/2026 at 18:00, 18 hours 59 minutes ago

    CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.

  • Published on 10/14/2026 at 17:40, 19 hours 19 minutes ago

    Mersen’s commitment to employee well-being earns it international Living Wage certification

  • Published on 10/14/2026 at 10:39, 1 day 2 hours ago

    Number of shares and voting rights - September 2026 (In French only)

  • Published on 10/14/2026 at 08:00, 1 day 4 hours ago

    Kerlink Launches Wirnet™ iEdge Series

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy